Morning Market Gainers

shares climbed 72 percent to $30.96 following Wednesday's announcement that Rhopressa Phase 3 trial has achieved primary endpoint.

surged 38.32 percent to $2.28. WaferGen Bio-systems presented new Single-Cell System results at the Single Cell Genomics Conference in Utrecht, The Netherlands.

shares surged 29.17 percent to $2.17 following announcement of the FDA Fast Track Designation for its CF102 in the treatment of liver cancer.

shares gained 15.87 percent to $33.07 after Altice SA agreed to buy Cablevision Systems for around $17.7 billion.

shares surged 15.95 percent to $12.50. Lakeland reported Q2 earnings of $0.28 per share on sales of $29.5 million.

shares gained 12.26 percent to $13.16 after the company announced a Special Protocol Assessment agreement with the FDA on the design of its Phase 3 clinical trial of TG-1101.

jumped 12.08 percent to $2.32 following announcement of national coverage agreement with UnitedHealthcare for prenatal diagnostic testing services.

shares rose 6.89 percent to $29.78 after the company reported better-than-expected earnings for its fiscal first quarter and issued a strong forecast for the current quarter.

surged 3.08 percent to $7.70. Inovio Pharmaceuticals published successful Phase 2b trial results of its HPV immunotherapy in The Lancet.